Details for New Drug Application (NDA): 020269
✉ Email this page to a colleague
NDA 020269 describes DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, which is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs. Additional details are available on the DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% profile page.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
Summary for 020269
| Tradename: | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% |
| Applicant: | Hospira |
| Ingredient: | dobutamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020269
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/100ML | ||||
| Approval Date: | Oct 19, 1993 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/100ML | ||||
| Approval Date: | Oct 19, 1993 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MG BASE/100ML | ||||
| Approval Date: | Oct 19, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
